Dr. Sarah Chen

Dr. Chen is a leading researcher in pediatric leukemia, specializing in CAR-T cell therapies for relapsed patients. She has published over 80 peer-reviewed articles and led multiple clinical trials that have transformed treatment for children with relapsed leukemia. Her research focuses on improving the safety and efficacy of CAR-T cell therapy while expanding access to these life-saving treatments. She is committed to ensuring that all children, regardless of their background, have access to the latest advances in leukemia treatment.